| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5912248 | Multiple Sclerosis and Related Disorders | 2014 | 8 Pages |
Abstract
Respondents taking natalizumab were more likely to experience tremor improvement than those taking other MS disease modifying therapies.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
John R. II, Amber R. Salter, Gary R. Cutter,